{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T16:55:26Z","timestamp":1742403326530,"version":"3.33.0"},"reference-count":7,"publisher":"Japanese Urological Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2024,1,20]]},"DOI":"10.5980\/jpnjurol.115.47","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T22:12:30Z","timestamp":1737324750000},"page":"47-51","source":"Crossref","is-referenced-by-count":1,"title":["A CASE OF SEVERE DRUG INDUCED ERUPTION AFTER APALUTAMIDE USE FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER, WHICH WAS DETERIORATED FROM TEMPORARY REMISSION AFTER DRUG WITHDRAWAL","\u8ee2\u79fb\u6027\u30db\u30eb\u30e2\u30f3\u611f\u53d7\u6027\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3057\uff0c\u30a2\u30d1\u30eb\u30bf\u30df\u30c9\u4f7f\u7528\u306b\u3066\u91cd\u75c7\u578b\u85ac\u75b9\u3092\u767a\u75c7\u3057\uff0c\u4f11\u85ac\u5f8c\u306b\u4e00\u6642\u6539\u5584\u50be\u5411\u3068\u306a\u308b\u3082\u518d\u71c3\u3057\u305f1\u4f8b"],"prefix":"10.5980","volume":"115","author":[{"given":"Baku","family":"Iijima","sequence":"first","affiliation":[{"name":"Department of Urology, Osaka Medical and Pharmaceutical University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Inamoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka Medical and Pharmaceutical University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka Medical and Pharmaceutical University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Komura","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka Medical and Pharmaceutical University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka Medical and Pharmaceutical University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","unstructured":"1) \u30a2\u30fc\u30ea\u30fc\u30c0\u9320 \u9069\u6b63\u4f7f\u7528\u30ac\u30a4\u30c9, p 4, p 12-28, \u30e4\u30f3\u30bb\u30f3\u30d5\u30a1\u30fc\u30de, \u65e5\u672c\u65b0\u85ac, \u6771\u4eac, 2022."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Uemura H, Koroki Y, Iwaki Y, Imanaka K, Kambara T, LopezGitlitz A, Smith A and Uemura H: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study. BMC Urol, 20, 139, 2020.","DOI":"10.1186\/s12894-020-00689-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Perez-Ruixo C, Ackaert O, Ouellet D, Chien C, Uemura H, Olmos D, Mainwaring P, Lee JY, Yu MK, Perez-Ruixo JJ, Smith MR and Small EJ: Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer. Clin Cancer, 26 (17), 4460-4467, 2020.","DOI":"10.1158\/1078-0432.CCR-20-1041"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) \u9ad8\u539f\u7531\u8863, \u68ee\u8107\u660c\u54c9, \u7530\u4e2d\u9ebb\u8863\u5b50, \u591a\u7530\u614e\u5e73, \u6ff5\u4e95\u5b8f\u4ecb, \u77f3\u5ddd\u66a2\u4e45, \u5c0f\u5200\u8309\u8036: \u6b7b\u4ea1\u8ee2\u5e30\u3092\u305f\u3069\u3063\u305f\u30a2\u30d1\u30eb\u30bf\u30df\u30c9\u306b\u3088\u308b\u85ac\u5264\u6027\u904e\u654f\u75c7\u75c7\u5019\u7fa4\u306e1\u4f8b. \u897f\u65e5\u672c\u76ae\u819a\u79d1, 84 (4), 308-311, 2022.","DOI":"10.2336\/nishinihonhifu.84.308"},{"key":"5","unstructured":"5) \u5869\u539f\u54f2\u592b, \u72e9\u91ce\u8449\u5b50, \u6c34\u5ddd\u826f\u5b50, \u4f50\u5c71\u6d69\u4e8c, \u6a4b\u672c\u516c\u4e8c, \u85e4\u5c71\u5e79\u5b50, \u76f8\u539f\u9053\u5b50, \u6c60\u6fa4\u5584\u90ce, \u677e\u5009\u7bc0\u5b50, \u672b\u6728\u535a\u5f66, \u98ef\u5cf6\u6b63\u6587, \u6e21\u9089\u79c0\u6643, \u68ee\u7530\u6804\u4f38, \u65b0\u539f\u5bdb\u4e4b, \u6d45\u7530\u79c0\u592b, \u5c0f\u8c46\u6fa4\u5b8f\u660e, \u5bae\u5ddd \u53f2, \u691b\u5cf6\u5065\u6cbb, \u4e2d\u5cf6\u6c99\u6075\u5b50, \u91ce\u6751\u5c1a\u53f2, \u6a4b\u722a\u79c0\u592b, \u963f\u90e8\u7406\u4e00\u90ce, \u9ad8\u6a4b\u52c7\u4eba, \u9752\u5c71\u7950\u7f8e, \u9ed2\u6ca2\u7f8e\u667a\u5b50, \u839a\u7530\u6cf0\u8aa0, \u5916\u5712\u5343\u6075, \u6728\u4e0b \u8302, \u4e0a\u7530\u771f\u7531\u7f8e: \u91cd\u75c7\u591a\u5f62\u7d05\u6591\u30fb\u30b9\u30c6\u30a3\u30fc\u30d6\u30f3\u30b8\u30e7\u30f3\u30bd\u30f3\u75c7\u5019\u7fa4\u30fb\u4e2d\u6bd2\u6027\u76ae\u819a\u58ca\u6b7b\u75c7\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3. \u65e5\u76ae\u4f1a\u8a8c, 126 (9), 1637-1685, 2016."},{"key":"6","unstructured":"6) \u65b0\u539f\u5bdb\u4e4b, \u68ee\u7530\u6804\u4f38: \u91cd\u75c7\u85ac\u75b9\u306b\u5bfe\u3059\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u30d1\u30eb\u30b9\u7642\u6cd5\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u591a\u65bd\u8a2d\u5171\u540c\u81e8\u5e8a\u7814\u7a76.\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1 (\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d) \u5206\u62c5\u7814\u7a76\u5831\u544a\u66f8. \u91cd\u75c7\u591a\u5f62\u6d78\u51fa\u6027\u7d05\u6591\u306b\u95a2\u3059\u308b\u8abf\u67fb\u7814\u7a76, 46-47, 2020."},{"key":"7","unstructured":"7) \u85e4\u5c71\u5e79\u5b50: \u85ac\u5264\u6027\u904e\u654f\u75c7\u75c7\u5019\u7fa4\u306e\u30b9\u30c6\u30ed\u30a4\u30c9\u6cbb\u7642\u3068\u5408\u4f75\u75c7\u306b\u95a2\u3059\u308b\u7814\u7a76.\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1 (\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d) \u5206\u62c5\u7814\u7a76\u5831\u544a\u66f8. \u91cd\u75c7\u591a\u5f62\u6d78\u51fa\u6027\u7d05\u6591\u306b\u95a2\u3059\u308b\u8abf\u67fb\u7814\u7a76, 35-37, 2020."}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/115\/1\/115_47\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:33:32Z","timestamp":1737779612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/115\/1\/115_47\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.115.47","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"type":"print","value":"0021-5287"},{"type":"electronic","value":"1884-7110"}],"subject":[],"published":{"date-parts":[[2024,1,20]]}}}